Kyle Gano, Chief Business Development Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 1,524 shares at $83.56 ($127K) on 2019-02-06, disclosed to the SEC on 2019-02-08.
Seasonal sale ($127k) by Chief Business Development Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.56 | 762 | $64K | 50.0% |
| 2 | $83.56 | 762 | $64K | 50.0% |
| Total | $83.56 avg | 1,524 | $127K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $598K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $471K | — | Filing → |